An open-label randomized clinical trial to evaluate the efficacy of everolimus versus tacrolimus in triple maintenance immunosuppressive therapy for kidney transplant patients

Tacrolimus (TAC), a calcineurin inhibitor, and everolimus (EVL), an mTOR inhibitor, have been used as immunosuppressive (ISS) drugs in post-kidney transplantation therapy. The objective of this study was to compare the efficacy of EVL vs TAC in the ISS maintenance triple therapy. Ninety-seven kidney...

Descripción completa

Detalles Bibliográficos
Autores principales: Assis, B.P.S., Lasmar, M.F., Fabreti-Oliveira, R.A., Araujo, S.A., Oliveira, J., Wanderley, D.C., Nascimento, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931813/
https://www.ncbi.nlm.nih.gov/pubmed/33681893
http://dx.doi.org/10.1590/1414-431X20209369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931813/
https://www.ncbi.nlm.nih.gov/pubmed/33681893
http://dx.doi.org/10.1590/1414-431X20209369

Ejemplares similares